Open letters

  • Email
  • Help

The European Medicines Agency (EMA) publishes open letters, usually in response to contributions and feedback from stakeholders.

Table of contents


Response to Nordic Cochrane Centre on safety review of human papillomavirus vaccines

Back to top

Clarifying the adaptive pathways concept

Back to top

Document(s) Language Status First published Last updated Effective Date
EMA response to a letter from a group of scientists clarifying the concept of adaptive pathways (English only)   2016-06-16    

Response to European Ombudsman explaining redaction rules

Back to top

Document(s) Language Status First published Last updated Effective Date
Letter to European Ombudsman (English only)   2015-02-10    

Response to European Ombudsman on clinical trial data transparency

Back to top

Document(s) Language Status First published Last updated Effective Date
European Medicines Agency letter to European Ombudsman regarding proactive publication of and access to clinical trial data (English only)   2014-05-22    

Letter to Member of European Parliament requesting correction

Back to top

Document(s) Language Status First published Last updated Effective Date
Letter from the European Medicines Agency to Ms M Rivasi regarding Dr Xavier Kurz (English only)   2011-10-26    

Response to British Medical Journal editorial on the new Agency

Back to top

Document(s) Language Status First published Last updated Effective Date
An open letter to the Editor of the British Medical Journal (English only)   1998-10-02